This is a registry, which means it collects information about patients with mitral valve disease, including mitral regurgitation (a leaky heart valve), mitral stenosis (a narrowed heart valve), and mixed mitral valve disease. The goal is to better understand how treating these conditions affects patients, especially those who might receive a new treatment called Transcatheter Mitral Valve Replacement (TMVR) using the Cephea Mitral Valve System. You might be able to join if you are 18 or older, have symptomatic mitral valve disease, and your heart team believes TMVR is a good option for you. The study aims to gather data for up to two years after you enroll.

Study design

This is an observational study that plans to enroll 1000 participants. It is not testing a specific intervention but rather collecting information about patients.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed from enrollment up to 2 years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.